ASMB
Assembly Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.60
+1.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- 66.55x
- PEG TTM
- —
- Price / book
- 2.44x
- Price / sales
- 9.96x
- Price / cash flow
- -19.37x
Enterprise value
- Enterprise value
- $427.2M
- EV / sales
- 5.71x
- EV / EBITDA
- 6282.16x
- EV / EBIT
- -48.55x
- Market cap
- $745.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026